REFERENCES
- Chang Y-W, Tsong Y., Dong X. (2014). Sample size determination for a three-arm equivalence trial of normally distributed responses. Journal of Biopharmaceutical Statistics 24(6):1190–1202.
- Chow, S. C., Liu, J. P. (1992). Design and Analysis of Bioavailability and Bioequivalence Studies. Statistics: Textbook and Monographs. New York, NY: Marcel Dekker.
- Chow, S. C., Shao, J., Wang, H. (2002). A note on sample size calculation for mean comparisons based on noncentral t-statistics. Journal of Biopharmaceutical Statistics 12(4):441–456.
- Chow, S.C., Shao, J., Wang, H. (2003). Sample Size Calculations in Clinical Research. Boca Raton, FL: CRC Press.
- Dong, X., Tsong, Y. (2014). Equivalence assessment for interchangeability based on two one-sided tests. Journal of Biopharmaceutical Statistics 24(6):1312–1331
- Food and Drug Administration. (1992). FDA Guidance for Industry: Statistical Procedures for Bioequivalence Studies Using a Standard Two Treatment Cross-Over Design. http://www.reocities.com/HotSprings/Spa/6896/stat-two.pdf
- Food and Drug Administration. (2003). FDA Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products: General Considerations. http://www.fda.gov/downloads/Drugs/Guidances/ucm070124.pdf
- Food and Drug Administration. (2001). FDA Guidance for Industry: Statistical Approaches to Establishing Bioequivalence. http://www.fda.gov/downloads/Drugs/Guidances/ucm070244.pdf
- Jones, B., Kenward, M.G. (2003). Design and Analysis of Cross-Over Trials, 2nd ed. London, UK: Chapman and Hall.
- Muirhead, R. J. (2005). Aspects of Multivariate Statistical Theory. New York, NY: John Wiley Sons.
- Satterthwaite, F. E. (1946). An approximate distribution of estimates of variance components. Biometrics Bulletin 2(6):110–114.
- Schuirmann, D. J. (1987). A comparison of the two one-sided tests procedure and the power approach. for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics 15:657–680.